Bectas Therapeutics, Inc. — Form D/A
Bectas Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2025-10-08. The offering totals $10.0M, of which $5.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-10-08
- Form: D/A
- Accession: 0002038826-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.5M
- Remaining: $4.5M
- Investors: 13
- Date of first sale: 2022-10-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-526249
Issuer
- Name: Bectas Therapeutics, Inc.
- CIK: 0002038826
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3262 WESTHEIMER ROAD, HOUSTON, TX, 77098
- Phone: 617-834-3476
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Lynda Chin | Director | Houston, TX |
| Ronan O'Hagan | Director | Houston, TX |
| Jon A Brilliant | Executive Officer | Houston, TX |
| Ronan O'Hagan | Executive Officer | Houston, TX |
Other filings by this issuer (1)
More